Liquid and Dissolvable ADHD Medications

Clinical Considerations for Formulation Selection

Extended-release chewable formulations, such as those using ion exchange technology, allow once-daily dosing, which improves medication adherence and reduces rebound effects compared to immediate-release preparations, as recommended by the American Academy of Pediatrics 1
Long-acting formulations are strongly preferred over short-acting preparations due to better medication adherence, lower risk of rebound effects, and more consistent symptom control throughout the day, according to the American Academy of Child and Adolescent Psychiatry 1, 2

Monitor blood pressure and pulse at baseline and regularly during treatment, as stimulants cause statistically significant increases that may be clinically relevant for patients with preexisting cardiovascular conditions, as advised by the American Heart Association 1
Track height and weight regularly, as psychostimulants are associated with statistically significant reductions in height and weight gain, though effects are usually minor, as reported by the National Institute of Mental Health 1
Common adverse effects include decreased appetite, sleep disturbances, increased blood pressure and pulse, headaches, irritability, and stomach pain, as noted by the FDA 1